News Releases
March 2 , 2009
ITI Announces Name Change and Update in Funding. VIEW PDF
December 8 , 2008
ITI Announces New Progress Milestones in its Development Program for Acute Repetitive Seizure in Epilepsy. VIEW PDF
July 8 , 2008
ITI Names Jeffrey Edelson, MD, Executive Vice President, R&D and Chief Medical Officer. VIEW PDF
November 9 , 2007
ITI Names Vice Presidents of Pharmaceutical Development and Commercial Development. VIEW PDF
April 4 , 2007
ITI Appoints Pharmaceutical Industry Veteran, Peter F. Young, as President and Chief Executive Officer. VIEW PDF
August 15 , 2006
ITI Closes $39.1 Million Series A Venture Financing; Company to Advance Clinical Programs in Areas of Pain Management and Central Nervous System Conditions. VIEW PDF
July 25, 2006
New ITI Study Shows Potential of Intranasal Midazolam as an Effective, Noninvasive Sedative. VIEW PDF
